Preventive Medicine: What It Is, Key Tests and Why It Matters

Preventive medicine is the branch of medicine focused on stopping diseases before they start, catching them early when they do appear, and reducing their impact when already present. Instead of waiting for illness to strike and then reacting, preventive medicine flips the script: measure, identify risks, and act while there is still time.

According to the WHO, noncommunicable diseases killed at least 43 million people in 2021, accounting for 75% of global non-pandemic deaths. Five factors — tobacco, physical inactivity, harmful alcohol use, unhealthy diets and air pollution — drive a large share of that risk. The opportunity is not endless testing: it is earlier action, with tests proportional to risk.

This article explains what preventive medicine is, how it differs from curative medicine, and why it matters more than ever — particularly if you care about living longer in good health. If you want to move from general prevention to a measurable plan, read our guide to personalized longevity protocols and evidence next.

At Progevita, prevention is connected to measurable programs: the Optimization Program, our longevity programs, the catalog of diagnostics and treatments, what a longevity clinic should measure and how to start a plan.

What is preventive medicine? A clear definition

Preventive medicine is the medical specialty dedicated to protecting health, preventing disease, and minimizing the consequences of conditions that have already appeared. It goes beyond annual checkups and vaccinations. Modern preventive medicine can use advanced biomarkers and precision diagnostics to identify actionable risks before symptoms show up, including joint health before mobility is lost.

The American College of Preventive Medicine defines it as the specialty combining clinical, biomedical, and public health sciences to protect, promote, and maintain health in individuals and defined populations.

What sets preventive medicine apart from other medical disciplines is its timing: it acts before disease, not after.

Preventive medicine vs curative medicine vs palliative care

To fully understand preventive medicine, it helps to see how it compares to the other two major approaches:

Type of Medicine	When it acts	Main goal	Example
Preventive	Before disease	Stop disease or catch it early	Biomarker panel detecting insulin resistance 5 years before diabetes diagnosis
Curative	During disease	Eliminate or control the condition	Metformin treatment for diagnosed type 2 diabetes
Palliative	In advanced stages	Relieve symptoms and improve quality of life	Pain management in advanced cancer

Curative medicine has been the backbone of healthcare systems for decades. It works well for acute conditions (infections, trauma, emergencies), but struggles with the chronic non-communicable diseases (NCDs) that are now the leading cause of death worldwide.

Here is a number that puts things in perspective: treating type 2 diabetes costs an average of €9,600 per patient per year in Spain (Crespo et al., Diabetes Care, 2013, PMID: 23468086). Preventing it through diet and exercise changes costs a fraction of that — and cuts the risk of developing diabetes by 58% (Knowler et al., NEJM, 2002, PMID: 11832527).

Preventive medicine does not replace curative care. It complements it. Prevention is most cost-effective when targeted: the right intervention, for the right risk, at the right moment.

The four levels of prevention

Preventive medicine is not one single thing. It is traditionally explained in three levels, but modern practice needs a fourth: avoiding harm from medical excess.

Primary prevention: keeping disease from happening

Primary prevention targets healthy people. The goal is to eliminate or reduce risk factors before they cause harm.

Concrete examples:

• Vaccination (the single highest-impact preventive intervention in history)
• Exercise programs to maintain VO₂max and muscle mass
• Evidence-based nutrition (Mediterranean diet, reducing ultra-processed food intake)
• Managing blood pressure, cholesterol, and fasting glucose levels
• Avoiding tobacco and excessive alcohol consumption

Primary prevention has the greatest potential when it acts on large, measurable risk factors: smoking, blood pressure, inactivity, excess visceral fat, poor sleep quality, diet, alcohol and metabolic risk. Not every preventive intervention saves money; the highest-value ones select who to intervene on and which decision will change.

At Progevita, primary prevention starts with the basics done well: medical history, examination, blood pressure, body composition, strength, aerobic capacity and indicated blood work. When the profile justifies it, advanced biomarkers — for example high-sensitivity CRP, suPAR, HOMA-IR, ApoB or Lp(a) — are added only when they are linked to a follow-up or intervention decision.

Secondary prevention: finding disease as early as possible

Secondary prevention focuses on early detection. When a disease has already started developing — even silently — catching it early makes the difference between a simple intervention and a complex one.

Concrete examples:

• Breast and colorectal cancer screening; prostate PSA testing through shared decision-making according to age, risk and preferences
• Detecting prediabetes through HbA1c before it progresses to full diabetes
• Carotid Doppler ultrasound only when there is a clinical indication or specific vascular suspicion
• Coronary calcium scoring in intermediate cardiovascular risk, when it can change treatment intensity

Early detection works. In the Minnesota trial, periodic fecal occult blood testing reduced colorectal-cancer mortality by roughly 22-32% depending on screening frequency (Shaukat et al., NEJM, 2013, PMID: 24047060). And catching hypertension early allows intervention through lifestyle changes before medication becomes necessary.

Tertiary prevention: minimizing the damage

Tertiary prevention acts when disease is already present. Its goal is not to cure (that is curative medicine's job), but to reduce complications, prevent relapse, and preserve the highest possible quality of life.

Concrete examples:

• Cardiac rehabilitation after a heart attack
• Continuous glucose monitoring in diabetic patients
• Physiotherapy protocols to prevent sarcopenia in patients with reduced mobility
• Adapted exercise programs to prevent falls in older adults

Across all levels, the principle is the same: act before the problem escalates, without turning a healthy person into a patient through overtesting.

Quaternary prevention: avoiding harm from overtesting

There is a fourth concept most search results skip, but it matters a lot in modern prevention: quaternary prevention. It means protecting people from unnecessary medical interventions: tests that do not change decisions, doubtful labels, treatments without a clear indication or anxiety created by trying to “optimize” every marker.

In longevity medicine this is especially important. A broad biomarker panel can be useful when it answers a clinical question; it can become noise when ordered without a hypothesis, age-appropriate reference ranges or a follow-up plan. Good prevention is not measuring everything. It is measuring enough to make better decisions.

The quaternary-prevention literature makes this explicit: healthcare overuse can create false positives, diagnostic cascades, anxiety and treatments without net benefit. In a BMJ Open qualitative study, clinicians and patients described barriers to applying this mindset, from social expectations to “do something” to the difficulty of discussing uncertainty (Otte et al., 2024, PMID: 38508616).

The same quaternary-prevention logic applies to advanced body imaging: Midjourney's ultrasound scanner is an interesting technology frontier, but it should not push mass screening without sensitivity, specificity, incidentaloma pathways and proven clinical utility.

Which tests matter in a preventive medicine assessment?

A useful preventive checkup combines official screening recommendations with actionable biomarkers. This table is a reasonable starting point for adults aged 35-65; it does not replace formal screening guidelines or individual review of family history, medication and symptoms.

Risk area	Useful tests	What decision they can change
Cardiometabolic risk	Blood pressure, ApoB, Lp(a), triglycerides, HbA1c, fasting glucose and insulin	Prioritize nutrition, exercise, visceral fat loss or medical treatment when risk is high
Chronic inflammation	High-sensitivity CRP, ferritin, blood count and, when available and decision-changing, suPAR	Distinguish persistent inflammation from recent infection, visceral fat or a hard training block
Body composition	Muscle mass, visceral fat, waist circumference and grip strength	Decide whether the first target is strength, fat loss, protein intake or recovery
Functional capacity	VO₂ max, strength tests, balance and mobility; HRV only as a recovery trend	Detect low physiological reserve before frailty appears
Age- and risk-based screening	Colon, breast, cervix, prostate, skin and bone health according to guidelines and family history	Catch disease early while avoiding tests outside indication

If a test will not change a decision — repeat, treat, refer, change habits or monitor — it is probably not a priority test. For the lab side, read our guide to longevity biomarkers; for cardiovascular risk, see our guides to ApoB and Lp(a).

High-value screening: what should not be missed

Advanced prevention does not replace official screening. It complements it. Before ordering sophisticated tests, make sure the basics are covered according to age, sex, family history and country:

Screening or measurement	Who / when it usually makes sense	Intended benefit	When to be cautious
Blood pressure	Adults periodically; earlier with excess weight, high stress, prior hypertensive pregnancy or family history	Detect silent hypertension and adjust habits or treatment	A single reading is not enough; repeat or use home/ambulatory readings when uncertain
Lipids, ApoB and Lp(a)	Adults with cardiovascular risk, family history or a need for finer cardiometabolic prevention	Reclassify risk and decide intensity of diet, exercise or medical therapy	Do not interpret cholesterol, ApoB or Lp(a) outside global risk, kidney function, blood pressure and age
Diabetes / prediabetes	Excess weight, high waist circumference, sedentary lifestyle, hypertension, family history, PCOS, fatty liver or midlife	Detect insulin resistance before diabetes	Glucose, HbA1c and insulin can disagree; context matters
Colorectal cancer	In Spain, population screening typically covers ages 50-69; many international guidelines consider starting at 45	Detect precursor lesions or early cancer	Direct colonoscopy without indication can add risk; strong family history changes the schedule
Breast cancer	In Spain, population mammography typically covers ages 50-69; USPSTF recommends every 2 years from 40 to 74 for average risk	Reduce mortality through earlier detection	More frequent screening is not always better: false positives, biopsies and overdiagnosis matter
Cervical cancer	Women aged 25-65 according to program: cytology and/or HPV testing by age band	Prevent cervical cancer by detecting lesions or persistent HPV infection	Duplicated testing outside schedule can create clinical noise
Lung and prostate	Lung: current/former smokers at high risk; prostate: shared decision-making by age, PSA, family history and preferences	Detect treatable early disease where net benefit is plausible	They are not universal screenings for every healthy adult

Exact ages differ between Spain, the EU, the US and regional health systems. The principle is stable: first use screenings with demonstrated net benefit; then add advanced biomarkers only when they create a new decision. Potential harms also matter: false positives, overdiagnosis, anxiety, radiation or unnecessary procedures.

Benefits of preventive medicine (backed by data)

The benefits of preventive medicine fall into three categories: financial, health-related, and personal.

Financial benefits

The numbers are stark, but they need careful interpretation. Chronic diseases represent a major share of European healthcare spending, and many share modifiable risk factors. That does not mean every checkup or advanced test automatically saves money.

A study published in Family Practice showed that preventive screenings in primary care for adults aged 30-49 increased life expectancy without raising healthcare costs over a 6-year follow-up period (Rasmussen et al., 2007, PMID: 17786799). Another observational study in Medicare Advantage beneficiaries found lower spending in a personalized preventive care model, but that should not be extrapolated as a universal promise (Musich et al., 2014, PMID: 25295675).

The practical conclusion is more sober: prevention creates value when it avoids serious events, detects treatable disease early or changes a concrete decision. Measurement for curiosity, without a plan, can add cost and noise.

Health benefits

Preventive medicine does not just add years to life — it adds life to years. The key concept here is healthspan: the years lived in good health with full autonomy.

In Spain, life expectancy is 83.2 years (INE, 2024), one of the highest in the world. But healthy life expectancy is only 68.3 years (Eurostat). That leaves a gap of nearly 15 years lived with some degree of illness or dependency.

Preventive medicine works to close that gap. The goal is not to live longer at any cost, but to make the years you do live good ones.

Autonomy and independence

Losing independence — being unable to walk unaided, depending on others for basic tasks, experiencing cognitive decline — ranks among the biggest fears associated with aging. Preventive medicine offers practical tools to delay or avoid this loss.

Grip strength, for instance, predicts mortality more reliably than blood pressure. Every 5 kg decrease in grip strength is linked to a 17% increase in all-cause mortality (Leong et al., Lancet, 2015, PMID: 25982160). Maintaining that strength through resistance training is preventive medicine at its most practical.

Similarly, VO₂max — the body's maximum oxygen consumption capacity — is one of the best modifiable markers of functional capacity. In a large cohort, people with better cardiorespiratory fitness had lower long-term mortality risk than those with low fitness (Mandsager et al., JAMA Network Open, 2018, PMID: 30646252).

Personalized preventive medicine in 2026: promise and limits

The real shift in 2026 is not “more checkups”. It is moving from generic prevention — the same advice for everyone — to risk-adjusted prevention: age, family history, blood pressure, lipids, glucose, kidney function, body composition, sleep, activity and, when useful, molecular biomarkers.

Cardiovascular risk is a good example. The American Heart Association published the PREVENT equations to estimate cardiovascular risk by integrating cardiovascular, kidney and metabolic health, not just total cholesterol and age (Khan et al., Circulation, 2024, PMID: 37947085). These models do not replace clinical judgment, but they help prioritize:

• whether low risk supports habits first and repeat measurement later;
• whether intermediate risk justifies ApoB, Lp(a), ambulatory blood pressure or coronary calcium assessment;
• whether high risk needs medical treatment in addition to lifestyle change.

The limits matter too. A 2025 review of reviews on personalized prevention identified 283 barriers to proper implementation: insufficient cost-effectiveness evidence in some uses, limited generalizability, privacy concerns, inequitable access and low personalized-prevention literacy among professionals and patients (Scarsi et al., PLoS One, 2025, PMID: 41134807). That is why the standard should not be “more data”. It should be interpretable, repeatable data connected to a plan.

How Progevita applies preventive medicine

Progevita is a longevity clinic located at Balneario de Cofrentes (Valencia, Spain), with over 50 medical professionals and 120 years of clinical history. Its model integrates advanced preventive medicine into longevity programs that combine diagnostics, treatment, and lifestyle interventions.

Rather than waiting for patients to get sick, Progevita measures what matters and acts on the findings. Here is how:

1. Advanced biomarker diagnostics

Everything starts with measurement. Progevita uses biomarker panels that go well beyond standard blood work:

• Chronic inflammation: high-sensitivity CRP, blood count, ferritin and suPAR/IL-6 only with clinical context
• Metabolism: HOMA-IR, HbA1c, fasting insulin
• Cardiovascular: full lipid profile (ApoB, Lp(a)); coronary calcium only when intermediate risk leaves treatment uncertainty
• Body composition: muscle mass, visceral fat and waist circumference
• Physical performance: VO₂max, grip strength, balance
• Oxidative stress: specific testing only when there is a clinical hypothesis and follow-up plan
• Cellular aging: epigenetic tests as longitudinal data, not a standalone diagnosis

This approach connects to Peter Attia's Medicine 3.0 framework (Outlive, 2023), with one caveat: measurement only matters when the result changes a clinical or lifestyle decision.

2. Preventive interventions: from established to experimental

Once risk factors are identified, Progevita prioritizes the interventions with the strongest clinical evidence first: exercise, nutrition, sleep, visceral fat loss when relevant, blood pressure control, medically assessed hormonal health and follow-up. Advanced therapies are presented as individualized support, not as substitutes for screening, diagnosis or conventional care.

Not every longevity treatment has evidence for reducing mortality or clinical events. Some interventions are used as biological support with indirect, emerging or indication-dependent evidence. That is why established measures must be separated from experimental ones, with contraindications, expectations and follow-up made explicit.

In the table, high means there are consistent trials, guidelines or clinical data for that goal; variable means it depends strongly on the indication; and emerging/experimental means it should not be marketed as proven event prevention or longevity extension.

Intervention	Evidence level	Reasonable use	What is not established / precautions
Supervised exercise	High	Improve VO₂ max, strength, balance, insulin sensitivity and blood pressure	Must be adapted to pain, frailty, medication, heart disease and recovery capacity
Personalized nutrition	High when based on validated dietary patterns	Reduce cardiometabolic risk, visceral fat and diet-related inflammation	Avoid extreme diets without indication, especially with sarcopenia, digestive disease or medication
Sleep, stress and alcohol	High for cardiometabolic risk and recovery	Improve blood pressure, glucose control, appetite, performance and adherence	Does not replace treatment for sleep apnea, depression, anxiety or addiction
Medical ozone therapy	Variable by indication	Complementary use under medical indication	Not a replacement for standard treatment; requires contraindication screening and realistic expectations
Orthomolecular IV / NAD+ therapy	Emerging and heterogeneous for longevity	Individualized support when there is a concrete clinical hypothesis	Not proven to reduce clinical events or mortality in healthy adults
Membrane plasmapheresis	High in approved indications; experimental for general rejuvenation	Medical procedure with specific indications and follow-up	Should not be presented as a universal anti-aging routine; requires risk, medication and goal review

This distinction matters: longevity marketing often blends interventions with very different evidence levels. At Progevita, treatments are integrated into 4- to 7-day programs that also include supervised exercise, personalized nutrition, sleep protocols, stress management and medical follow-up.

3. Structured prevention programs

Progevita offers five programs, each designed for a specific prevention profile:

Program	Prevention focus	Typical profile
Optimization	Biomarkers + physical performance + habits	People who want a complete, actionable baseline
Inflammaging	Chronic inflammation + oxidative stress	Fatigue, pain, poor recovery or suspected persistent inflammation
Leadership Path	Executive stress + cognitive function + sleep	High cognitive load or impaired sleep
Detox Reset	Guided fasting + metabolic reset + detoxification	People who need to reset habits and metabolism with supervision
Women's Vital Path	Female hormonal health + perimenopause	Women with hormonal changes affecting sleep, energy or body composition

Every program includes medical consultation, diagnostics, treatments, personalized nutrition, daily exercise, and a 12-month follow-up plan. The difference from a standard checkup is that here, prevention comes with action.

Why preventive medicine matters more than ever

The treat-the-sick model of healthcare has a sustainability problem. Chronic noncommunicable diseases (cardiovascular disease, diabetes, cancer, respiratory disease and neurodegenerative conditions) caused at least 43 million deaths in 2021, according to the WHO, and their costs keep climbing.

At the same time, longevity science has advanced enough to identify molecular mechanisms of aging — the 12 hallmarks of aging described by López-Otín et al. in Cell (2023, PMID: 36599349) — and to formulate more precise preventive hypotheses. Some have strong clinical evidence; others remain experimental.

This means preventive medicine can cautiously integrate layers beyond vaccines and screenings:

• Longitudinal tracking of biological aging with epigenetic clocks, interpreted cautiously
• Detecting low-grade chronic inflammation (inflammaging) through high-sensitivity CRP, clinical context and, when indicated, suPAR
• Assessing mitochondrial function and energy; therapies such as NAD+ require individual indication and realistic expectations
• Specific exercise protocols to improve VO₂max, a practical marker of cardiorespiratory reserve

Modern preventive medicine increasingly overlaps with longevity medicine: instead of waiting for the body to fail, you measure what matters, act proportionally and correct risk before it becomes disease.

Frequently asked questions about preventive medicine

What exactly is preventive medicine?

Preventive medicine is the medical specialty focused on stopping diseases before they appear, detecting them in early stages, and reducing their complications when they already exist. It includes everything from vaccination and screening programs to the use of advanced biomarkers for identifying individual risk factors.

What are the benefits of preventive medicine?

Preventive medicine can reduce complications, improve quality of life, extend healthspan and help maintain independence as you age. The key word is “can”: the benefit depends on choosing interventions with net benefit and avoiding unnecessary tests. A Medicare Advantage observational study found lower spending in one personalized preventive care model, but it should be read as supportive evidence, not as a universal guarantee (Musich et al., 2014, PMID: 25295675).

How is preventive medicine different from curative medicine?

Preventive medicine acts before disease or in its earliest stages. Curative medicine acts when disease is already present, aiming to eliminate or control it. Both are necessary and complementary. The key difference is timing: the earlier an actionable risk is found, the more options exist to correct it with less harm.

What are examples of preventive medicine?

Classic examples include vaccination, age- and risk-based cancer screening, and blood pressure, lipid and glucose monitoring. Advanced examples can include VO₂ max, strength, body composition, high-sensitivity CRP, ApoB, Lp(a), HbA1c, sleep, HRV as a trend or epigenetic age testing, as long as the result will change a decision.

When should I start with preventive medicine?

As early as possible. Risk factors for chronic diseases begin accumulating from your 30s and 40s, even though symptoms may not appear until decades later. A preventive checkup between ages 35 and 45 can detect metabolic, cardiovascular, and inflammatory risks at a stage where they are still easy to correct.

What is the connection between preventive medicine and longevity?

Preventive medicine and longevity medicine share the same goal: extending healthy lifespan. Longevity medicine applies the same principles — measure, prevent, act — with more emphasis on biomarkers, physical function, metabolic health, sleep, hormones and longitudinal follow-up. Not everything sold as “anti-aging” has the same evidence level, so it is important to separate proven, plausible and experimental interventions.

Is preventive medicine expensive?

It depends on scope. Official screening and basic preventive measures — blood pressure, vaccination, habits, indicated blood work — are usually low-cost compared with treating chronic complications. An advanced assessment costs more, so it should produce concrete decisions: which risk is being measured, which intervention will change and when the measurement will be repeated.

Medical transparency

Article updated in June 2026. Medical author: Dr. Miguel Ángel Fernández Torán. This information is educational and should be interpreted alongside your medical history, medication, family history and the official screenings that apply to you. Progevita offers medical prevention and longevity programs; that does not mean every advanced test or therapy is necessary for every person.

References

1. WHO, "Noncommunicable diseases fact sheet", 2025
2. American College of Preventive Medicine, "What is Preventive Medicine?", accessed 2026
3. USPSTF, "A and B Recommendations", accessed 2026
4. Spanish Ministry of Health, population cancer screening programs in Spain
5. Knowler WC et al., "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", NEJM, 2002 (PMID: 11832527)
6. Crespo C et al., "Direct cost of diabetes mellitus and its complications in Spain", Diabetes Care, 2013 (PMID: 23468086)
7. Shaukat A et al., "Long-term mortality after screening for colorectal cancer", NEJM, 2013 (PMID: 24047060)
8. Rasmussen SR et al., "Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs", Family Practice, 2007 (PMID: 17786799)
9. Musich S et al., "Personalized preventive care reduces healthcare expenditures among Medicare Advantage beneficiaries", Am J Manag Care, 2014 (PMID: 25295675)
10. Leong DP et al., "Prognostic value of grip strength", Lancet, 2015 (PMID: 25982160)
11. Mandsager K et al., "Association of cardiorespiratory fitness with long-term mortality", JAMA Network Open, 2018 (PMID: 30646252)
12. Khan SS et al., "Development and Validation of the American Heart Association's PREVENT Equations", Circulation, 2024 (PMID: 37947085)
13. Scarsi N et al., "Mapping the state-of-the-art of the barriers for personalized preventive approaches worldwide", PLoS One, 2025 (PMID: 41134807)
14. Otte JA et al., "Enablers and barriers to a quaternary prevention approach", BMJ Open, 2024 (PMID: 38508616)
15. López-Otín C et al., "Hallmarks of aging: An expanding universe", Cell, 2023 (PMID: 36599349)

This article is for informational purposes and does not replace medical consultation.

Want to learn how preventive medicine can help you live longer and better? Book a consultation with our medical team and design a personalized program at Balneario de Cofrentes.